ABIN362515
antibody from antibodies-online
Targeting: NFKB1
KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN362515 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 1 (NFKB1) (AA 891-895) antibody
- Antibody type
- Polyclonal
- Antigen
- Peptide sequence around AA 891-895 (A-S-S-P-V) derived from Human NFkB-p105. Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.
- Description
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 891-895
- Isotype
- IgG
- Vial size
- 50 μL
- Concentration
- 1 mg/mL
- Storage
- Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Submitted references Phosphorylation of serine 337 of NF-kappaB p50 is critical for DNA binding.
NF-kappa B: ten years after.
Function and activation of NF-kappa B in the immune system.
Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.
Hou S, Guan H, Ricciardi RP
The Journal of biological chemistry 2003 Nov 14;278(46):45994-8
The Journal of biological chemistry 2003 Nov 14;278(46):45994-8
NF-kappa B: ten years after.
Baeuerle PA, Baltimore D
Cell 1996 Oct 4;87(1):13-20
Cell 1996 Oct 4;87(1):13-20
Function and activation of NF-kappa B in the immune system.
Baeuerle PA, Henkel T
Annual review of immunology 1994;12:141-79
Annual review of immunology 1994;12:141-79
Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.
Haskill S, Beg AA, Tompkins SM, Morris JS, Yurochko AD, Sampson-Johannes A, Mondal K, Ralph P, Baldwin AS Jr
Cell 1991 Jun 28;65(7):1281-9
Cell 1991 Jun 28;65(7):1281-9
No comments: Submit comment
No validations: Submit validation data